Acadian Asset Management’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29K Hold
17,416
﹤0.01% 1544
2025
Q1
$29K Hold
17,416
﹤0.01% 1500
2024
Q4
$38K Hold
17,416
﹤0.01% 1493
2024
Q3
$46K Sell
17,416
-7
-0% -$18 ﹤0.01% 1815
2024
Q2
$55K Hold
17,423
﹤0.01% 1596
2024
Q1
$44K Hold
17,423
﹤0.01% 1397
2023
Q4
$107K Hold
17,423
﹤0.01% 1346
2023
Q3
$120K Sell
17,423
-4,040
-19% -$27.8K ﹤0.01% 1281
2023
Q2
$195K Sell
21,463
-6,878
-24% -$62.5K ﹤0.01% 1279
2023
Q1
$44K Hold
28,341
﹤0.01% 1531
2022
Q4
$44K Sell
28,341
-1,393
-5% -$2.16K ﹤0.01% 1593
2022
Q3
$274K Sell
29,734
-191,350
-87% -$1.76M ﹤0.01% 1134
2022
Q2
$732K Sell
221,084
-2
-0% -$7 ﹤0.01% 879
2022
Q1
$1.47M Hold
221,086
0.01% 745
2021
Q4
$1.41M Buy
221,086
+7,276
+3% +$46.5K 0.01% 748
2021
Q3
$2.97M Sell
213,810
-9,094
-4% -$126K 0.01% 578
2021
Q2
$4.14M Buy
222,904
+5,202
+2% +$96.5K 0.02% 516
2021
Q1
$5.09M Buy
217,702
+3,971
+2% +$92.8K 0.02% 474
2020
Q4
$4M Buy
213,731
+582
+0.3% +$10.9K 0.02% 565
2020
Q3
$5.42M Buy
213,149
+98,935
+87% +$2.52M 0.02% 420
2020
Q2
$3.3M Buy
114,214
+90,740
+387% +$2.62M 0.01% 583
2020
Q1
$1.13M Buy
23,474
+12,611
+116% +$607K 0.01% 753
2019
Q4
$618K Buy
10,863
+6,081
+127% +$346K ﹤0.01% 1020
2019
Q3
$296K Sell
4,782
-2,471
-34% -$153K ﹤0.01% 1222
2019
Q2
$326K Buy
7,253
+3,111
+75% +$140K ﹤0.01% 1117
2019
Q1
$261K Sell
4,142
-5,385
-57% -$339K ﹤0.01% 1288
2018
Q4
$514K Buy
9,527
+4,174
+78% +$225K ﹤0.01% 894
2018
Q3
$538K Buy
5,353
+1,345
+34% +$135K ﹤0.01% 866
2018
Q2
$265K Buy
4,008
+3,075
+330% +$203K ﹤0.01% 1012
2018
Q1
$47K Buy
+933
New +$47K ﹤0.01% 1368